Implementing a closed cell therapy manufacturing process through strategic collaboration

The need for standardization of cell therapy manufacturing continues to be a critical driver of technological advancement and investments. Implementation of a scalable, integrated workflow can minimize open processes and reduce manual touchpoints, ultimately reducing manufacturing failures. New innovations in closed, modular, cell therapy-specific instrumentation enable the development of robust and reproducible, end-to-end manufacturing processes for commercial applications. In this article, we discuss solutions for standardizing manufacturing processes, and explain how strategic collaborations can help streamline the transition to the commercialization pipeline. 

Please enter your email to access content Read now